Model-based Cost-effectiveness of State-level Latent Tuberculosis Interventions in California, Florida, New York, and Texas.
Youngji JoSourya ShresthaIsabella GomesSuzanne MarksAndrew HillGarrett AsayDavid DowdyPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
The modeled cost-effectiveness of TTT for LTBI varies across states but was consistently greatest among people with HIV; moderate among people who are non-US-born, incarcerated, or homeless; and least cost-effective among people with diabetes.
Keyphrases
- hiv aids
- antiretroviral therapy
- type diabetes
- hiv positive
- hiv infected
- human immunodeficiency virus
- mycobacterium tuberculosis
- hiv testing
- cardiovascular disease
- hepatitis c virus
- glycemic control
- gestational age
- high intensity
- men who have sex with men
- mental illness
- low birth weight
- mental health
- adverse drug
- adipose tissue
- metabolic syndrome
- skeletal muscle
- electronic health record